Search Results - "Joensuu, Kristiina"

Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar by Mutka, Minna, Joensuu, Kristiina, Eray, Mine, Heikkilä, Päivi

“…Much is known about tumor infiltrating lymphocytes (Tils) in primary breast cancer, as this has been the focus of much research in recent years, but regarding…”
Get full text

Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch by Haughian, James M, Pinto, Mauricio P, Harrell, J. Chuck, Bliesner, Brian S, Joensuu, Kristiina M, Dye, Wendy W, Sartorius, Carol A, Tan, Aik Choon, Heikkilä, Päivi, Perou, Charles M, Horwitz, Kathryn B

“…Luminal breast cancers express estrogen (ER) and/or progesterone (PR) receptors and respond to hormone therapies. Basal-like "triple negative" cancers lack…”
Get full text

Tumor dormancy: Elevated expression of stanniocalcins in late relapsing breast cancer by Joensuu, Kristiina, Heikkilä, Päivi, Andersson, Leif C

“…Abstract Background Breast cancer is known for its propensity to recur even after decades. The biology behind this phenomenon of tumor dormancy is poorly…”
Get full text

ER,PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer- Reduced CK5 Expression in Metastases by Joensuu, Kristiina, Leidenius, Marjut, Kero, Mia, Andersson, Leif C., Horwitz, Kathryn B., Heikkilä, Päivi

“…Breast cancer can recur even decades after the primary therapy. Markers are needed to predict cancer progression and the risk of late recurrence. The estrogen…”
Get full text

High expression of maspin is associated with early tumor relapse in breast cancer by Joensuu, Kristiina M., MD, Leidenius, Marjut H.K., MD, PhD, Andersson, Leif C., MD, PhD, Heikkilä, Päivi S., MD, PhD

“…Summary Maspin is a serine protease inhibitor with tumor suppressor activity. Maspin can suppress tumor growth and metastasis in vivo and tumor cell motility…”
Get full text

High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer by Heiskala, Marja, Leidenius, Marjut, Joensuu, Kristiina, Heikkilä, Päivi

“…Macrophages are important for the function of the innate immune system, and in solid tumors, they represent a significant proportion of the tumor mass…”
Get full text

Core needle biopsy changes the expression of TGFβ1 and TGFβRII at protein level, and the distribution of CD4 and CD8 positive T cells in primary breast cancer by Joensuu, Kristiina, Heiskala, Marja, Heikkilä, Päivi

“…Core needle biopsy (CNB) has become a paradigm in preoperative breast cancer (BC) diagnosis. Although considered safe, it is an invasive procedure, which…”
Get full text

Clever-1 positive macrophages in breast cancer by Mutka, Minna, Virtakoivu, Reetta, Joensuu, Kristiina, Hollmén, Maija, Heikkilä, Päivi

“…Purpose Common Lymphatic Endothelial and Vascular Endothelial Receptor 1 (Clever-1) is expressed by a subset of immunosuppressive macrophages and targeting the…”
Get full text

Core needle biopsies alter the amounts of CCR5, Siglec-15, and PD-L1 positivities in breast carcinoma by Mutka, Minna, Joensuu, Kristiina, Heiskala, Marja, Eray, Mine, Heikkilä, Päivi

“…Core needle biopsies (CNB) are widely used to diagnose breast cancer, but the procedure is invasive and thus, it changes the tumor microenvironment. The…”
Get full text

Core Needle Biopsy Enhances the Activity of the CCL2/CCR2 Pathway in the Microenvironment of Invasive Breast Cancer by Heiskala, Marja, Joensuu, Kristiina, Heikkilä, Päivi

“…The use of core needle biopsy (CNB) as a means to verify malignancy preoperatively is a paradigm in current breast cancer care, and the risk of enhancing tumor…”
Get full text

Social Proximity and Environmental NGO Relationships in Corporate Sustainability Reports by Joensuu, Kristiina, Koskela, Marileena, Onkila, Tiina

“…This study demonstrates how three Finnish companies constructed their stakeholder relationships with environmental NGOs (ENGOs) in terms of social proximity in…”
Get full text

Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases by Strien, Leena, Joensuu, Kristiina, Heikkilä, Päivi, Leidenius, Marjut H

“…Luminal A breast cancers (BC) represent low-risk tumors conferring better outcome than luminal B and human epidermal growth factor 2 (HER2)-positive or…”
Get full text

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells by Ogba, Ndiya, Manning, Nicole G, Bliesner, Brian S, Ambler, S Kelly, Haughian, James M, Pinto, Mauricio P, Jedlicka, Paul, Joensuu, Kristiina, Heikkilä, Päivi, Horwitz, Kathryn B

“…Luminal, estrogen receptor-positive (ER(+)) breast cancers can metastasize but lie dormant for years before recurrences prove lethal. Understanding the roles…”
Get full text

Social Proximity and Environmental NGO Relationships in Corporate Sustainability Reports: Social Proximity in Corporate-ENGO Relationships by Joensuu, Kristiina, Koskela, Marileena, Onkila, Tiina

Get full text

Implications of Managerial Framing of Stakeholders in Environmental Reports by Onkila, Tiina, Joensuu, Kristiina, Koskela, Marileena

“…Corporate environmental reports are increasingly viewed as products of the managerial framing of responsibility and stakeholders. This notion encouraged us to…”
Get full text

Bmi-1, c-myc, and Snail expression in primary breast cancers and their metastases—elevated Bmi-1 expression in late breast cancer relapses by Joensuu, Kristiina, Hagström, Jaana, Leidenius, Marjut, Haglund, Caj, Andersson, Leif C, Sariola, Hannu, Heikkilä, Päivi

“…Breast cancer is known for its propensity to recur decades after treatment. The biology behind the phenomenon of tumor dormancy is still poorly understood…”
Get full text

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases by Kristiina Joensuu, Marjut Leidenius, Mia Kero, Leif C. Andersson, Kathryn B. Horwitz, Päivi Heikkilä

“…Breast cancer can recur even decades after the primary therapy. Markers are needed to predict cancer progression and the risk of late recurrence. The estrogen…”
Get full text

Fatal epithelioid haemangioendothelioma presenting in the lung and liver by Ekfors, Tauno O., Joensuu, Kristiina, Toivio, Ilkka, Laurinen, Paula, Pelttari, Lisa

Get full text

Dormancy of tumor cells by Strien, Leena, Joensuu, Kristiina, Heikkilä, Päivi

“…Whereas tumor dormancy occurs in melanomas, renal carcinomas and non-Hodgkin lymphomas, late recurrence is characteristic of breast cancer in particular. In…”
Get full text